7:30 - 8:00

8:00 – 8:05  

8:05 – 8:10

8:10 – 8:15

8:15 – 8:20

8:20 – 8:25

8:25 – 8:35

8:35 – 8:45

8:45 – 8:55

8:55 – 9:10   

9:10 – 9:25

9:25 – 9:40

9:40 – 10:40

10:40 – 10:55

10:55 – 11:10 

11:10 – 11:25

11:25 – 11:40

11:40 – 12:40

12:40 – 1:40

1:40 – 1:55

1:55 – 2:10

2:10 – 2:25   

2:25 – 4:25   

4:25 – 5:00

5:00

Meeting Materials Pick Up

Welcome & Goals – Food and Drug Administration (FDA) 

Welcome – American Academy of Ophthalmology (AAO)

Welcome – American Academy of Optometry (AAOpt)

Welcome – American Optometric Association (AOA)

Welcome – Contact Lens Association of Ophthalmologists (CLAO)

Regulation of Contact Lenses and Associated Care Products 

Preclinical Test Methods for Contact Lenses and their Care Products

History & Rationale for the Panel of Test Organisms for Contact Lens Care Products

PANEL 1:  Emerging Pathogens in Contact Lens-Related Keratitis

Panelists: Suzi Fleiszig, OD, PhD, Michelle Callegan, PhD, Mark Willcox, PhD, Eduardo Alfonso, MD, Jennifer Cope, MD, MPH (CDC), Elmer Tu, MD, John Dart, MD

Causes of Contact Lens-Related Infectious Keratitis in the U.S.: Historical Trends and Emerging Pathogens

International Patterns of Contact Lens- Related Infectious Keratitis

Impact of Changing Water Restrictions on Contact Lens-Related Infectious Keratitis

Panel Discussion Question #1 

BREAK

Panel 2:  Role of Soil in Disinfection Efficacy Testing

Panelists: Carol Lakkis, PhD, Suzi Fleiszig, OD, PhD, Michelle Callegan, PhD, Mark Willcox, PhD, Ralph Stone, PhD 

Definition of Organic Soil and the Relevant Components of an Artificial Tear Model

Incorporating Soil in the Preclinical Testing of Contact Lenses and their Products: Historical Perspective & Current Methods

Measuring the Efficacy of Organic Soil Removal

Panel Discussion Question #2

LUNCH

Panel 3:  Acanthamoeba:  The Organism and Test Methods

Panelists: Donald Ahearn, PhD, Simon Kilvington, PhD, Elmer Tu, MD, Ralph Stone, PhD, Mary Mowrey-McKee, PhD 

Acanthamoeba Keratitis: Biology of the Organism and Host Factors (view slide presentation)

Disinfection Efficacy Test Methods for Acanthamoeba

Disinfection Efficacy Test Methods for Acanthamoeba 

Panel Discussion Questions #3-5

Closing Remarks

CLAO

AOA

AAOpt

AAO

FDA

ADJOURN

Malvina Eydelman, MD

Thomas Steinemann, MD

Loretta Szczotka-Flynn, OD, PhD

Joseph Shovlin, OD

Deborah Jacobs, MD

Denise Hampton, PhD (FDA)

Jeffrey Brocious, MS (FDA)

Ralph Stone, PhD

Moderator: Loretta Szczotka-Flynn, OD, PhD (AAO)

Jennifer Cope, MD, MPH (CDC)

John Dart, MD

Elmer Tu, MD 

Moderator: Michael Dueñas, OD, (AOA)
 

Mark Willcox, PhD

Scott Steffen, PhD (FDA)

Joseph Hutter, PhD (FDA)

Moderator: Deepinder Dhaliwal, MD
 

Donald Ahearn, PhD

Daniel Fedorko, PhD (FDA)

Simon Kilvington, PhD

Deepinder Dhaliwal, MD

Michael Duenas, OD

Loretta Szczotka-Flynn, OD, PhD

Thomas Steinemann, MD

Malvina Eydelman, MD